Back to search
Respiratory Distress Syndrome in Premature Infant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Respiratory Distress Syndrome in Premature Infant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Respiratory Distress Syndrome in Premature Infant trials you may qualify forMany babies born very preterm (\<32 weeks of pregnancy) require support to breathe from a breathing machine (mechanical ventilator) via a breathing tube. Althou…
Respiratory distress syndrome (RDS) is a common cause of respiratory failure in preterm infants and is frequently treated with surfactant therapy. With the incr…
The primary objective of this study is to compare work of breathing indices before and after extubation in intubated premature infants admitted to the Christian…
Being born too early (preterm birth) is the leading cause of death in children world-wide. In Australia, 97% of very preterm babies who are admitted to Neonatal…
This is a 2-part, prospective, randomized, blinded, sham-controlled, multi-center study comparing preterm subjects with RDS who are treated with APC-0101 and nC…
This prospective, non-randomized, unblinded pilot study evaluates and compares the intrapulmonary distribution of exogenous surfactant in preterm neonates when…
People with acute respiratory failure usually require the use of an artificial breathing machine, known as a mechanical ventilator. Sedative medications, which…
Evidence suggests that increased intravascular and interstitial fluid load in neonates with transient tachypnea of the newborn (TTN) may delay the clearance of…
The goal of this observational study is to evaluate different methods of surfactant administration in preterm infants with respiratory distress syndrome (RDS).…